SLE (Finngen)

SLE_FG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints SLE_OTH SLE_NOS M13_SLE	1355
6. Filter based on genotype QC (FinnGen only)	1355

Control definitions (FinnGen only)

Control exclude: AUTOIMMUNE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SLE_FG
CONTROL_EXCLUDE	AUTOIMMUNE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	SLE_OTH\|SLE_NOS\|M13_SLE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to SLE (Finngen) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8433	6670	1687
Only index persons	6978	5653	1325
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.05
Only index persons	0.18	0.21	0.05
Median age at first event (years)
Whole population	50.68	49.61	54.71
Only index persons	48.57	47.43	53.43

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1355	1118	237
Unadjusted period prevalence (%)	0.33	0.38	0.10
Median age at first event (years)	47.08	45.61	53.98

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1244: Matched controls
12439

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4503599627370496.0

323.0

1028

L04AX01

ATC

azathioprine; systemic

195.1

323.0

361

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

155.3

323.0

844

166

P01BA02

ATC

hydroxychloroquine; oral

185.6

323.0

886

163

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

314.3

288

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

39.2

293.5

376

136

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

35.5

282.4

371

147

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3120.7

282.2

262

H02AB06

ATC

prednisolone; systemic

8.4

247.6

958

3533

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

245.1

227

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

229.4

213

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.5

200.3

764

2448

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

254.9

193.5

194

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

185.1

173

L04AA06

ATC

mycophenolic acid; systemic

78.7

177.4

199

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1953.8

173.0

164

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

19.5

163.5

257

164

L93.0

ICD-10 Finland

Discoid lupus erythematosus

305.5

160.6

160

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

141.0

152.2

160

M32

ICD-10 Finland

Systemic lupus erythematosus

1555.8

144.7

138

H02AB07

ATC

prednisone; oral

6.9

142.0

411

830

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

132.7

125

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.4

128.8

721

2972

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

10.1

127.4

272

334

H03AA01

ATC

levothyroxine sodium; systemic

8.8

126.3

296

427

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.0

112.8

279

432

L88

ICPC

Rheumatoid/seropositive arthritis

37.1

112.7

145

M05BA04

ATC

alendronic acid; oral

7.9

110.5

275

429

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

100.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

17.6

95.1

153

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

93.9

R50.9

ICD-10 Finland

Fever, unspecified

4.7

76.9

299

784

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.3

69.6

461

1888

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.1

69.4

206

394

L04AD01

ATC

ciclosporin; systemic

29.6

67.2

C08CA05

ATC

nifedipine; systemic

7.4

67.1

170

261

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

35.0

65.5

H02AB04

ATC

methylprednisolone; systemic

4.0

64.8

304

937

L04AA01

ATC

[U] ciclosporin; systemic

33.6

60.4

C03CA01

ATC

furosemide; systemic

3.2

59.4

387

1534

A02BC02

ATC

pantoprazole; systemic

2.7

57.5

898

6049

A07EC01

ATC

sulfasalazine; oral, rectal

9.4

57.5

123

143

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

157.4

57.4

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

68.4

56.8

XX9XE

NOMESCO Finland

Other ultrasound examination

62.2

56.0

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

34.6

55.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

5.2

55.2

185

403

ZX120

NOMESCO Finland

Intravenous

4.7

55.1

204

495

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

54.4

624

3482

L04AA13

ATC

leflunomide; oral

65.1

53.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.2

52.2

329

1254

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

52.1

240

715

E0000UV

ATC

2.5

49.9

591

3303

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.4

49.7

274

942

H04.10

ICD-10 Finland

Dry eye syndrome

4.2

49.2

208

571

P01BA01

ATC

chloroquine; systemic

135.5

49.2

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

47.1

327

1322

J01MA12

ATC

levofloxacin; systemic

3.2

46.4

290

1089

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

18.6

46.3

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

46.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.0

45.2

307

1216

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

44.0

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

32.5

42.6

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

69.6

41.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.1

41.2

176

484

D68.8

ICD-10 Finland

Other specified coagulation defects

19.1

40.5

M13.9

ICD-10 Finland

Arthritis, unspecified

5.1

40.2

134

287

K90.0

ICD-10 Finland

Coeliac disease

31.8

39.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

39.5

255

969

J01FF01

ATC

clindamycin; systemic

2.5

39.1

405

2037

N02AX02

ATC

tramadol; systemic, rectal

2.3

38.8

561

3325

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

38.3

174

504

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

388.8

38.2

D07AC01

ATC

betamethasone; topical

2.3

38.2

468

2558

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

37.7

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.4

37.0

101

169

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

36.8

325

1490

D07AB08

ATC

desonide; topical

3.4

36.3

198

660

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

27.7

35.2

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

356.8

35.1

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.5

34.9

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

123.4

33.8

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

+∞

33.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.7

33.1

271

1179

B01AA03

ATC

warfarin; systemic

2.8

33.1

237

953

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.2

32.3

155

J01FA06

ATC

roxithromycin; oral

2.1

31.5

566

3580

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

31.4

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

6.3

31.3

145

A02BC03

ATC

lansoprazole; oral

2.2

31.3

407

2241

M05BA07

ATC

risedronic acid; oral

6.7

31.0

128

J01MA02

ATC

ciprofloxacin; systemic

2.1

30.6

489

2939

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

30.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

15.4

29.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.2

29.4

117

299

SBA10

NOMESCO Finland

Measurement of excretion of saliva

19.8

29.3

A02BC01

ATC

omeprazole; systemic

2.2

29.1

377

2059

J05AB01

ATC

aciclovir; systemic

2.3

29.0

323

1642

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

28.9

228

964

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

21.7

28.8

104

Kela drug reimbursment

Thyroid insufficiency

5.7

28.7

158

UJF30

NOMESCO Finland

Ileoscopy through colon

3.4

28.6

149

478

R06.0

ICD-10 Finland

Dyspnoea

2.3

28.5

334

1738

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

21.7

27.5

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.6

27.5

158

E000001

ATC

2.3

27.3

304

1537

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

27.3

151

505

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

27.2

540

3489

B01AB05

ATC

enoxaparin; parenteral

2.1

26.9

404

2333

N03AX16

ATC

pregabalin; oral

2.2

26.8

319

1666

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

10.2

26.6

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.8

26.6

R4120

NOMESCO Finland

Occupational therapy

3.9

26.3

113

309

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.8

26.1

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

31.7

26.0

M05BB03

ATC

alendronic acid and colecalciferol; oral

7.5

26.0

J01DB01

ATC

cefalexin; oral

2.2

26.0

1032

8588

L01AA01

ATC

cyclophosphamide; systemic

74.3

25.9

C08CA01

ATC

amlodipine; oral

2.1

25.8

400

2334

B07.9

ICD-10 Finland

Verruca simplex

5.4

25.8

153

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

25.8

176

680

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.5

25.6

217

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

45.3

25.6

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

25.4

334

1816

XPX04

NOMESCO Finland

Angioscopy

36.4

25.3

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

11.6

25.3

UJF32

NOMESCO Finland

Coloscopy

2.2

25.2

310

1637

M25.5

ICD-10 Finland

Pain in joint

2.0

25.1

398

2338

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

10.2

24.7

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

8.3

24.6

J05AB11

ATC

valaciclovir; oral

2.5

24.2

219

993

N03AX12

ATC

gabapentin; oral

2.5

24.1

216

974

H26.3

ICD-10 Finland

Drug-induced cataract

26.0

24.0

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

24.0

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.0

24.0

152

559

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

24.0

115

345

I73.0

ICD-10 Finland

Raynaud syndrome

9.9

23.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.1

23.8

243

R4110

NOMESCO Finland

Physiotherapy

2.0

23.6

357

2050

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.8

23.1

164

645

1XC02

NOMESCO Finland

22.6

23.1

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

22.6

23.1

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

23.0

D07AC13

ATC

mometasone; topical

2.0

22.9

384

2288

M05BX04

ATC

denosumab; parenteral

4.2

22.9

232

K51.5

ICD-10 Finland

Left sided colitis

234.1

22.7

L99

ICPC

Musculoskeletal disease other

8.1

22.6

XW000

NOMESCO Finland

Bone marrow biopsy

5.1

22.5

147

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.3

22.3

J01DA01

ATC

[U] cefalexin; systemic

1.8

22.2

799

6171

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

22.2

124

416

NF1AA

NOMESCO Finland

Hip X-ray examination

3.1

22.2

127

435

N18.0

ICD-10 Finland

End-stage renal disease

21.9

22.2

A46

ICD-10 Finland

Erysipelas

2.7

22.1

169

696

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

22.1

370

2199

A02BC05

ATC

esomeprazole; systemic

1.8

22.1

525

3536

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

25.6

21.8

D07AD01

ATC

clobetasol; topical

2.4

21.8

214

1008

M01CB01

ATC

sodium aurothiomalate; parenteral

39.4

21.8

Z94.0

ICD-10 Finland

Kidney transplant status

22.7

21.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

21.7

227

1101

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

21.7

125

430

L04AB04

ATC

adalimumab; parenteral

44.2

21.5

L40.0

ICD-10 Finland

Psoriasis vulgaris

14.2

21.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.1

21.4

125

432

Z49.1

ICD-10 Finland

Extracorporeal dialysis

15.8

21.1

TNG10

NOMESCO Finland

Puncture of knee

16.9

21.0

107

Kela drug reimbursment

Pernicious anaemia

+∞

20.9

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

+∞

20.9

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

20.9

H20.1

ICD-10 Finland

Chronic iridocyclitis

+∞

20.9

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

20.9

L40.5

ICD-10 Finland

Arthropathic psoriasis

213.4

20.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.2

20.6

113

376

A07AA02

ATC

nystatin; oral

3.3

20.5

106

337

E03

ICD-10 Finland

Other hypothyroidism

8.7

20.5

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.4

20.5

177

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.4

20.4

104

327

J01MA14

ATC

moxifloxacin; systemic

3.0

20.4

125

446

B02.9

ICD-10 Finland

Zoster without complication

3.6

20.3

279

A11CC03

ATC

alfacalcidol; systemic

8.6

20.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

6.5

20.2

N06AA09

ATC

amitriptyline; systemic

2.6

20.1

154

633

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.3

20.1

185

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.6

20.0

272

E03.89

ICD-10 Finland

Other specified hypothyroidism

10.3

19.9

N02AA05

ATC

oxycodone; systemic

2.5

19.9

168

730

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

19.8

N02BE01

ATC

paracetamol; systemic, rectal

2.1

19.8

1064

9223

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

19.7

161

687

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

19.6

173

767

M81.4

ICD-10 Finland

Drug-induced osteoporosis

203.0

19.6

B03XA02

ATC

darbepoetin alfa; parenteral

9.4

19.4

XQ848

NOMESCO Finland

Dermatological photography

6.3

19.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

19.3

167

735

D70.89

ICD-10 Finland

Neutropenic splenomegaly

11.2

19.3

WZA10

NOMESCO Finland

Long statement of health and health related matters

8.9

19.0

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

7.6

18.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

28.3

18.8

L04AB01

ATC

etanercept; parenteral

28.3

18.8

N32.9

ICD-10 Finland

Bladder disorder, unspecified

28.3

18.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

18.7

106

360

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

101.6

18.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

18.5

190

M01AH02

ATC

rofecoxib; oral

2.4

18.4

176

813

R51.80

ICD-10 Finland

Headache

2.2

18.4

210

1056

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.9

18.4

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

30.5

18.4

N18.8

ICD-10 Finland

Other chronic renal failure

8.1

18.4

C08CA02

ATC

felodipine; oral

2.9

18.3

116

425

127

Kela drug reimbursment

Transplant complication

11.2

18.3

L95

ICPC

Osteoporosis

4.7

18.2

136

M79.7

ICD-10 Finland

Fibromyalgia

4.3

18.2

164

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

18.2

156

680

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.3

17.9

318

Kela drug reimbursment

Teriparatide

20.4

17.8

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

67.6

17.8

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

17.7

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

+∞

17.7

TAB00

NOMESCO Finland

Lumbar puncture

4.0

17.7

193

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

17.7

560

4036

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.5

17.6

146

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.4

17.6

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

10.2

17.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.4

17.4

ZX140

NOMESCO Finland

Intra articular

21.2

17.3

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.6

17.3

228

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

17.3

456

3107

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

17.2

490

3411

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

9.0

17.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

17.2

117

449

M05BA06

ATC

ibandronic acid; systemic

6.0

17.0

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.5

17.0

142

L28

ICPC

Limited function/disability (L)

2.2

16.9

186

916

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.2

16.9

288

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

16.8

115

442

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

16.8

146

643

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

16.7

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

16.7

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

+∞

16.7

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

172.2

16.5

L01BB01

ATC

172.2

16.5

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

18.2

16.5

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.1

16.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

16.5

125

508

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.5

16.4

233

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

16.3

172

832

J01AA02

ATC

doxycycline; systemic

1.8

16.3

952

8086

C09AA02

ATC

enalapril; systemic

2.1

16.3

203

1057

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

16.1

129

541

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

16.1

248

M05BA01

ATC

etidronic acid; systemic

18.8

16.0

A12AA04

ATC

calcium carbonate; oral

10.9

16.0

WW200

NOMESCO Finland

Immunization

5.4

16.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

16.0

220

1192

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

15.9

142

630

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.4

15.9

245

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

15.8

447

3088

TK800

NOMESCO Finland

Hemodialysis

6.9

15.8

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

15.8

119

485

ZXA00

NOMESCO Finland

Right side

1.8

15.7

320

1999

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

+∞

15.7

L93

ICD-10 Finland

Lupus erythematosus

+∞

15.7

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

15.7

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

17.5

15.6

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

161.9

15.5

A02BA02

ATC

ranitidine; systemic

1.9

15.5

238

1347

A07EA06

ATC

budesonide; oral, local oral

6.8

15.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.4

15.3

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

15.2

411

2795

137

Kela drug reimbursment

Uraemia requiring dialysis

18.0

15.2

WX002

NOMESCO Finland

Sedation and analgesia

1.9

15.1

240

1372

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.3

15.1

135

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

15.0

324

205

Kela drug reimbursment

Chronic hypertension

1.9

15.0

272

1629

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

15.0

372

C07AB07

ATC

bisoprolol; oral

1.7

14.9

484

3461

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.4

14.9

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.8

14.9

176

R13

ICD-10 Finland

Dysphagia

3.1

14.9

290

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

14.9

283

A07EC02

ATC

mesalazine; oral, rectal

5.5

14.9

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

15.3

14.9

C02CA01

ATC

prazosin; oral

12.6

14.9

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

12.6

14.9

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.2

14.8

H02AB09

ATC

hydrocortisone; systemic

6.3

14.8

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

14.6

69540

ICD-8 Finland

Erythematous condition, Lupus erythematosus

+∞

14.6

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

81.1

14.6

SPAT1263

SPAT

Sampling

1.6

14.6

501

3632

J02AC01

ATC

fluconazole; systemic

1.6

14.5

571

4288

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.9

14.5

160

L84

ICD-10 Finland

Corns and callosities

4.3

14.5

126

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

36.5

14.5

H04AA01

ATC

glucagon; nasal, parenteral

36.5

14.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

14.4

545

4049

S97

ICPC

Chronic ulcer skin

3.6

14.4

187

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

14.4

132

595

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.3

14.3

135

618

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

14.2

112

468

NH3AE

NOMESCO Finland

Feet ultrasound examination

43.0

14.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.7

14.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

14.6

14.1

R03AC02

ATC

salbutamol; inhalant

1.6

14.0

641

4990

P01AB01

ATC

metronidazole; oral, rectal

1.6

13.9

513

3776

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

13.9

225

AA1AD

NOMESCO Finland

CT of head and brain

1.8

13.9

257

1548

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

53.9

13.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

13.8

354

2358

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.3

13.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

10.6

13.8

M79.6

ICD-10 Finland

Pain in limb

1.6

13.7

430

3026

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

13.7

194

1058

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.5

13.7

195

K50.9

ICD-10 Finland

Crohn disease, unspecified

76.0

13.6

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

14.9

13.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

13.6

334

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

+∞

13.6

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

13.6

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

+∞

13.6

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

+∞

13.6

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

5.9

13.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

13.5

208

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.7

13.5

377

2571

H05AA02

ATC

teriparatide; parenteral

16.4

13.5

TGC00

NOMESCO Finland

Bronchial lavation

5.2

13.4

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

13.4

177

Z49.2

ICD-10 Finland

Other dialysis

18.4

13.4

B05DA

ATC

Isotonic solutions

18.4

13.4

R06AE07

ATC

cetirizine; oral

1.6

13.4

547

4118

ULA02

NOMESCO Finland

Kolposcopy

2.1

13.3

155

782

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

13.2

171

899

JN4BD

NOMESCO Finland

Extensive body CT

2.3

13.2

130

608

M31.1

ICD-10 Finland

Thrombotic microangiopathy

40.5

13.2

M01AE02

ATC

naproxen; oral, rectal

1.6

13.2

689

5500

E000002

ATC

2.1

13.1

148

736

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.4

13.1

197

A41.9

ICD-10 Finland

Sepsis, unspecified

4.5

13.1

106

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8.9

13.0

M13.0

ICD-10 Finland

Polyarthritis, unspecified

8.9

13.0

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

16.9

13.0

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

16.9

13.0

6BA02

NOMESCO Finland

28.7

13.0

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

13.0

133

633

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.5

13.0

ZXA05

NOMESCO Finland

Left side

1.7

12.9

293

1875

A10AA01

ATC

22.8

12.9

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

7.0

12.9

WX110

NOMESCO Finland

Local anesthesy

1.6

12.9

832

6974

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

12.9

188

1038

R05

ICD-10 Finland

Cough

1.8

12.9

239

1437

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

12.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.9

12.9

277

L17

ICPC

Foot/toe symptom/complaint

1.7

12.8

289

1850

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.7

12.8

158

WX203

NOMESCO Finland

Infraclavicular plexus blockade

5.0

12.7

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.8

12.6

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

12.5

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

12.5

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

12.5

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

+∞

12.5

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

12.5

E10

ICD-10 Finland

Type 1 diabetes mellitus

24.6

12.5

NDL52

NOMESCO Finland

Tenosynovectomy of hand

24.6

12.5

D07AA02

ATC

hydrocortisone; topical

2.0

12.5

175

949

N05CF01

ATC

zopiclone; oral

1.6

12.5

367

2529

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

131.2

12.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

12.4

359

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

12.4

408

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

12.4

104

448

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

12.4

432

3108

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

12.3

287

S76

ICPC

Skin infection other

3.0

12.3

239

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.1

12.2

118

T86

ICPC

Hypothyroidism/myxoedema

6.8

12.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

12.2

217

1281

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

37.9

12.2

A01AB04

ATC

amphotericin B; local oral

3.0

12.1

243

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

12.1

141

712

A12BA01

ATC

potassium chloride; oral

3.5

12.0

166

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

21.5

12.0

B05DB

ATC

Hypertonic solutions

21.5

12.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

12.0

456

3346

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

11.9

327

2205

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

11.9

178

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

11.9

152

797

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

11.8

308

2048

N02AC04

ATC

dextropropoxyphene; oral

3.8

11.8

137

PAW37

NOMESCO Finland

Biopsy of temporal artery

14.8

11.8

H26.2

ICD-10 Finland

Complicated cataract

9.0

11.8

ZX108

NOMESCO Finland

Inhalation

9.7

11.8

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

11.7

275

1772

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.4

11.7

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

11.7

409

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.8

11.6

129

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

11.6

122

589

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

11.5

170

940

D02AX

ATC

Other emollients and protectives

3.5

11.5

156

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

+∞

11.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

11.4

295

M33.2

ICD-10 Finland

Polymyositis

121.1

11.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.6

11.4

TQW80

NOMESCO Finland

Local dermatologic skincare

4.6

11.3

E000006

ATC

2.4

11.3

423

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

8.4

11.3

A01

ICPC

Pain general/multiple sites

2.3

11.3

103

465

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.6

11.2

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

11.2

102

460

R76.0

ICD-10 Finland

Raised antibody titre

25.3

11.1

V03AE02

ATC

sevelamer; oral

25.3

11.1

3AC01

NOMESCO Finland

8.1

11.1

E000003

ATC

3.2

11.1

189

D02BB01

ATC

betacarotene; oral

11.3

11.1

WX204

NOMESCO Finland

Axillary plexus blockaced

3.9

11.0

115

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

11.0

204

1220

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

11.0

202

1204

WX320

NOMESCO Finland

Spinalanesthesy

1.7

11.0

258

1658

5BA08

NOMESCO Finland

14.0

11.0

M06

ICD-10 Finland

Other rheumatoid arthritis

43.7

10.9

RT272

NOMESCO Finland

43.7

10.9

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

43.7

10.9

RJ421

NOMESCO Finland

43.7

10.9

J01FA10

ATC

azithromycin; systemic

1.5

10.9

694

5684

H26.4

ICD-10 Finland

After-cataract

2.4

10.9

399

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.2

10.9

114

546

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

12.0

10.8

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

12.0

10.8

N30.0

ICD-10 Finland

Acute cystitis

1.9

10.8

179

1031

B03XA01

ATC

erythropoietin; parenteral

15.6

10.8

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

8.3

10.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

10.8

144

767

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

10.8

278

1836

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.3

10.7

160

N06AX21

ATC

duloxetine; oral

2.1

10.7

130

666

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

10.6

351

K51.8

ICD-10 Finland

Other ulcerative colitis

60.5

10.6

SPAT1325

SPAT

Vaccination

1.6

10.6

361

2563

A10AA02

ATC

10.1

10.5

S18

ICPC

Laceration/cut

1.5

10.5

439

3271

B03BA03

ATC

hydroxocobalamin; parenteral

3.6

10.5

136

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

14.3

10.5

D02AE01

ATC

carbamide; topical

2.4

10.5

395

C02KX01

ATC

bosentan; oral

110.9

10.4

K50.8

ICD-10 Finland

Other Crohn disease

110.9

10.4

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

10.4

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

+∞

10.4

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

10.4

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

+∞

10.4

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

10.4

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

10.4

304

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

10.4

180

1051

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

10.4

322

2230

E000007

ATC

2.5

10.3

343

A01AC01

ATC

triamcinolone; local oral

5.2

10.3

RJ411

NOMESCO Finland

32.8

10.3

A28

ICPC

Limited function/disability NOS

2.0

10.3

142

765

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

19.0

10.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

10.3

189

1125

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.5

10.3

334

K07.60

ICD-10 Finland

Snapping jaw

2.6

10.2

283

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

10.2

119

600

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

10.2

275

A01AB10

ATC

natamycin; local oral

3.5

10.2

134

XCK00

NOMESCO Finland

Perimetry

2.5

10.1

322

D06BB04

ATC

podophyllotoxin; topical

2.7

10.1

267

A01AB09

ATC

miconazole; local oral

2.1

10.1

112

553

K11.2

ICD-10 Finland

Sialoadenitis

3.3

10.1

151

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

10.1

254

1662

L50.9

ICD-10 Finland

Urticaria, unspecified

3.1

10.0

180

WX892

NOMESCO Finland

Monitored bed care

2.4

10.0

345

RJ410

NOMESCO Finland

40.4

10.0

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

9.9

339

XF404

NOMESCO Finland

Ambulatory ECG

2.1

9.9

110

542

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.3

9.9

148

GD1AD

NOMESCO Finland

Thorax CT examination

3.1

9.9

176

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

16.8

9.9

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

9.9

393

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

12.3

9.9

J01EA01

ATC

trimethoprim; systemic

1.6

9.8

318

2222

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

9.8

118

602

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

26.2

9.8

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

26.2

9.8

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

26.2

9.8

XA800

NOMESCO Finland

Neuropsychological investigation

2.9

9.8

212

D06BX01

ATC

metronidazole; topical

1.9

9.8

141

771

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

9.7

443

D01AE16

ATC

amorolfine; topical

1.9

9.7

139

757

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

9.7

403

NDG30

NOMESCO Finland

Fusion of wrist, total

55.4

9.7

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.2

9.6

157

B01AB04

ATC

dalteparin; parenteral

2.7

9.6

250

EBA10

NOMESCO Finland

Surgical removal of tooth

1.9

9.6

140

769

R05

ICPC

Cough

1.6

9.6

253

1677

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.5

9.5

R80

ICD-10 Finland

Isolated proteinuria

9.2

9.5

R53

ICD-10 Finland

Malaise and fatigue

1.7

9.5

225

1446

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

9.5

171

1012

N03AF02

ATC

oxcarbazepine; oral

3.3

9.5

148

TEA00

NOMESCO Finland

Biopsy of lip

7.6

9.4

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

100.7

9.4

RT274

NOMESCO Finland

100.7

9.4

K50.1

ICD-10 Finland

Crohn disease of large intestine

100.7

9.4

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.4

9.4

322

M35.2

ICD-10 Finland

Behçet disease

+∞

9.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

9.4

H3603, E103

ICD-10 Finland

+∞

9.4

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.0

9.3

114

587

UJD02

NOMESCO Finland

Gastroscopy

2.8

9.3

212

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.6

9.3

113

C07AB02

ATC

metoprolol; systemic

1.7

9.3

206

1300

T89

ICPC

Diabetes insulin dependent

6.1

9.2

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

7.3

9.2

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.5

9.2

L71.9

ICD-10 Finland

Rosacea, unspecified

4.0

9.2

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.8

9.2

207

C02DE02

ATC

6.8

9.1

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.0

9.1

H25.0

ICD-10 Finland

Senile incipient cataract

2.6

9.1

247

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.4

9.1

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.4

9.1

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.1

9.0

O99.7

ICD-10 Finland

Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

37.0

9.0

RJ511

NOMESCO Finland

37.0

9.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

9.0

252

1692

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

8.9

189

B01AC04

ATC

clopidogrel; oral

1.9

8.9

131

721

SPAT1153

SPAT

Removal of sutures

1.5

8.9

337

2432

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.4

8.9

300

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

8.9

586

4751

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.2

8.9

B81

ICPC

Anaemia vit B12/folate deficiency

4.2

8.9

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

8.9

128

SPAT1229

SPAT

Assessment of need for aid

2.3

8.9

386

S01KA02

ATC

hypromellose; ophthalmic

4.1

8.9

R4190

NOMESCO Finland

Nutritional therapy

3.2

8.9

139

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

8.9

421

X58

ICD-10 Finland

Exposure to other specified factors

1.8

8.9

147

847

M54.5

ICD-10 Finland

Low back pain

1.5

8.9

374

2771

Z50.1

ICD-10 Finland

Other physical therapy

2.4

8.9

302

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

8.8

139

784

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

8.8

137

771

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

8.8

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.0

8.8

172

K29.4

ICD-10 Finland

Chronic atrophic gastritis

5.7

8.8

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

8.7

211

1362

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.1

8.7

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

50.3

8.7

WW400

NOMESCO Finland

Plasmaferesis

50.3

8.7

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.6

8.7

104

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

8.7

147

853

WW500

NOMESCO Finland

Blood transfusion

2.8

8.6

188

N05BA01

ATC

diazepam; systemic, rectal

1.8

8.6

150

877

UKC02

NOMESCO Finland

Cystoscopy

1.9

8.6

136

770

L71.8

ICD-10 Finland

Other rosacea

4.8

8.6

M01AX17

ATC

nimesulide; oral

1.6

8.6

264

1814

A02BA04

ATC

nizatidine; systemic

2.2

8.5

440

EB1WA

NOMESCO Finland

9.1

8.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

8.5

247

1670

C03AA03

ATC

hydrochlorothiazide; oral

2.1

8.5

100

505

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

8.5

250

R03BB04

ATC

tiotropium bromide; inhalant

2.1

8.5

455

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

27.7

8.5

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

27.7

8.5

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

27.7

8.5

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

20.2

8.5

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

6.0

8.5

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.4

8.5

C07AG02

ATC

carvedilol; oral

2.6

8.5

244

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

8.4

170

1040

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

8.4

112

N07AA02

ATC

pyridostigmine; systemic

90.6

8.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

90.6

8.4

G35

ICD-10 Finland

Multiple sclerosis

90.6

8.4

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.5

8.4

107

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

8.4

272

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

12.9

8.4

ZZA00

NOMESCO Finland

Split skin graft

3.9

8.4

H3601, E103

ICD-10 Finland

+∞

8.3

7100A

ICD-10 Finland

+∞

8.3

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

8.3

9522

FHL

Synovectomy

+∞

8.3

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

8.3

24409

ICD-8 Finland

Myxoedema, (hypothyreosis) NUD

+∞

8.3

H3600, E103

ICD-10 Finland

+∞

8.3

L04AA17

ATC

[U] adalimumab; parenteral

+∞

8.3

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

+∞

8.3

K50.0

ICD-10 Finland

Crohn disease of small intestine

+∞

8.3

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

8.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

8.3

259

1784

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

8.3

466

SPAT1255

SPAT

Intravenous administration of medicine

2.4

8.3

285

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

8.3

128

717

M48.0

ICD-10 Finland

Spinal stenosis

1.9

8.3

119

651

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

8.3

325

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

8.3

157

941

V03AE01

ATC

polystyrene sulfonate; oral

9.5

8.3

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.4

8.3

114

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.0

8.2

162

S01AD03

ATC

aciclovir; ophthalmic

3.0

8.2

153

K02.1

ICD-10 Finland

Caries of dentine

1.4

8.2

649

5415

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.0

8.2

S01AX11

ATC

[U] ofloxacin; ophthalmic

3.1

8.2

142

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

8.2

104

NG1DA

NOMESCO Finland

X-ray of knees

4.6

8.2

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.0

8.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.8

8.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

8.1

333

2438

M79.1

ICD-10 Finland

Myalgia

1.8

8.1

154

927

M01CB03

ATC

auranofin; oral

17.3

8.1

UJF92

NOMESCO Finland

Capsular endoscopy

4.5

8.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.9

8.1

166

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

3.0

8.1

159

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

9.0

8.0

SPAT1254

SPAT

Administration of medicine

1.8

8.0

142

836

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

10.1

8.0

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

6.3

8.0

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

22.2

8.0

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.9

8.0

167

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.6

8.0

S09

ICPC

Infected finger/toe

3.3

8.0

117

C01DA14

ATC

isosorbide mononitrate; oral

1.9

8.0

114

623

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.3

8.0

M01AB55

ATC

diclofenac, combinations; oral

2.2

8.0

378

M01AX01

ATC

nabumetone; oral

2.7

7.9

208

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

7.9

261

N06AB04

ATC

citalopram; systemic

1.6

7.9

245

1684

N05CD07

ATC

temazepam; oral

1.9

7.9

123

694

J01MA06

ATC

norfloxacin; oral

1.7

7.9

176

1110

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

7.9

115

632

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.8

7.9

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

7.9

395

R04.0

ICD-10 Finland

Epistaxis

2.3

7.9

305

ZXA10

NOMESCO Finland

Bilateral

1.6

7.8

197

1286

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

7.8

460

A10AE04

ATC

insulin glargine; parenteral

2.5

7.8

256

A04

ICPC

Weakness/tiredness general

1.8

7.8

140

827

SBB10

NOMESCO Finland

Teeth copy

2.3

7.8

339

R4180

NOMESCO Finland

Podiatric therapy

8.5

7.8

GD2SN

NOMESCO Finland

Lung ventilation SPECT

10.9

7.8

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

10.9

7.8

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.2

7.8

120

SBA00

NOMESCO Finland

Microbiological examinations

3.5

7.7

RT271

NOMESCO Finland

45.2

7.7

RJ412

NOMESCO Finland

45.2

7.7

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

45.2

7.7

RJ210

NOMESCO Finland

45.2

7.7

RJ420

NOMESCO Finland

45.2

7.7

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.2

7.7

121

ZZH31

NOMESCO Finland

Bone allograft, small pieces

7.5

7.7

H15.1

ICD-10 Finland

Episcleritis

4.8

7.6

RS221

NOMESCO Finland

4.8

7.6

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.2

7.6

326

D06BB10

ATC

imiquimod; topical

2.5

7.6

246

A08

ICPC

Swelling

2.8

7.6

177

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.6

7.6

I51.4

ICD-10 Finland

Myocarditis, unspecified

11.9

7.6

WZA90

NOMESCO Finland

Other doctors statement

1.5

7.6

260

1830

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

7.6

154

946

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

7.5

134

K76.9

ICD-10 Finland

Liver disease, unspecified

5.5

7.5

M45

ICD-10 Finland

Ankylosing spondylitis

4.7

7.5

C09CA01

ATC

losartan; oral

1.6

7.5

232

1591

A99

ICPC

Disease/condition unspecnature/site

2.1

7.5

444

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

7.5

110

605

N06AX11

ATC

mirtazapine; oral

1.5

7.5

349

2621

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

7.4

396

AN1

Coronary angiography

2.0

7.4

504

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.0

7.4

505

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

7.4

337

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

80.5

7.4

M35

ICD-10 Finland

Other systemic involvement of connective tissue

80.5

7.4

N25.0

ICD-10 Finland

Renal osteodystrophy

80.5

7.4

RT172

NOMESCO Finland

80.5

7.4

L04AB05

ATC

certolizumab pegol; parenteral

80.5

7.4

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

80.5

7.4

L56.4

ICD-10 Finland

Polymorphous light eruption

13.4

7.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

7.4

330

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.4

7.3

R11

ICD-10 Finland

Nausea and vomiting

2.0

7.3

442

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.1

7.3

120

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.8

7.3

116

657

I50.1

ICD-10 Finland

Left ventricular failure

3.1

7.3

126

6954B

ICD-9 Finland

Erythematous conditions, Lupus erythematosus[LUPUS ERYTHEMATOSUS DISCOIDES DISSEMINATUS]

+∞

7.3

74310

ICD-8 Finland

Other congenital anomalies of nervous system, Microcephalus

+∞

7.3

L04AA11

ATC

[U] etanercept; parenteral

+∞

7.3

G70.0

ICD-10 Finland

Myasthenia gravis

+∞

7.3

M05.2

ICD-10 Finland

Rheumatoid vasculitis

+∞

7.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

7.3

I68.2*M32.1

ICD-10 Finland

Cerebral arteritis in systemic lupus erythematosus

+∞

7.3

4AA26

NOMESCO Finland

+∞

7.3

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

+∞

7.3

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

9.4

7.3

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.5

7.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.5

7.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

7.3

426

3339

C02EA02

ATC

3.0

7.3

138

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.0

7.3

138

C01CA24

ATC

epinephrine; parenteral

2.1

7.3

409

A03

ICPC

Fever

1.6

7.2

176

1136

SPAT1262

SPAT

Handing over of treatment supplies

1.7

7.2

154

956

N32.1

ICD-10 Finland

Vesicointestinal fistula

15.8

7.2

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

4.1

7.2

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

7.2

374

Z71.8

ICD-10 Finland

Other specified counselling

1.5

7.2

273

1961

J01XE01

ATC

nitrofurantoin; oral

4.0

7.2

J01FA09

ATC

clarithromycin; systemic

1.4

7.2

355

2696

C08CA13

ATC

lercanidipine; oral

1.8

7.2

129

763

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

4.8

7.2

D69.0

ICD-10 Finland

Allergic purpura

30.2

7.2

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

30.2

7.2

R50.0

ICD-10 Finland

Fever with chills

30.2

7.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

7.1

485

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

20.1

7.1

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

20.1

7.1

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

8.0

7.1

R03BA05

ATC

fluticasone; inhalant

1.6

7.1

201

1349

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

4.6

7.1

D05BB02

ATC

acitretin; oral

6.1

7.1

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.5

7.1

226

R42

ICD-10 Finland

Dizziness and giddiness

1.6

7.1

223

1535

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

7.0

523

N89.0

ICD-10 Finland

Mild vaginal dysplasia

10.1

7.0

G62.8

ICD-10 Finland

Other specified polyneuropathies

10.1

7.0

GD1UN

NOMESCO Finland

Lung circulation SPECT

10.1

7.0

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

7.0

211

N01BB02

ATC

lidocaine; parenteral

7.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

7.0

134

806

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

7.0

271

C02AC05

ATC

moxonidine; oral

2.8

7.0

153

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.1

7.0

119

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

7.0

170

1098

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

6.4

6.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.3

6.9

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.2

6.9

319

M35.7

ICD-10 Finland

Hypermobility syndrome

4.1

6.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

6.9

120

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

13.9

6.9

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

6.9

600

5031

ZX100

NOMESCO Finland

Oral

4.8

6.9

XCH00

NOMESCO Finland

Eye pressure measurement

2.7

6.9

173

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

6.8

227

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.2

6.8

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.6

6.8

N29

ICPC

Neurological sympt/complt other

3.9

6.8

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

6.8

270

XF402

NOMESCO Finland

ECG with work load test

1.8

6.8

108

614

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

40.3

6.8

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

40.3

6.8

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

16.8

6.7

RD210

NOMESCO Finland

4.3

6.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

6.7

265

1916

L50.0

ICD-10 Finland

Allergic urticaria

3.3

6.7

100

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

6.7

284

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

22.6

6.7

L04AB06

ATC

golimumab; parenteral

22.6

6.7

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

2.5

6.7

195

H01.0

ICD-10 Finland

Blepharitis

2.2

6.7

307

SPAT1216

SPAT

Assessment of functional ability

1.7

6.6

144

901

M81.8

ICD-10 Finland

Other osteoporosis

6.5

6.6

R4140

NOMESCO Finland

Psychotherapy

6.5

6.6

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

6.6

312

S01XA18

ATC

ciclosporin; ophthalmic

7.8

6.6

NHQ40

NOMESCO Finland

Amputation of toe

5.5

6.6

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

6.6

164

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.7

6.6

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

6.5

477

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

6.5

420

M04AA01

ATC

allopurinol; systemic

1.9

6.5

478

ZXC00

NOMESCO Finland

Use of diathermy

6.9

6.5

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

6.5

136

Z01.2

ICD-10 Finland

Dental examination

1.4

6.5

469

3799

R00.2

ICD-10 Finland

Palpitations

1.9

6.5

496

LEB00

NOMESCO Finland

Biopsy of vagina

3.3

6.5

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

6.5

N03AX14

ATC

levetiracetam; systemic

3.2

6.5

103

L14

ICPC

Leg/thigh symptom/complaint

2.0

6.5

396

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

70.2

6.4

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

70.2

6.4

RT171

NOMESCO Finland

70.2

6.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

70.2

6.4

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.7

6.4

L12

ICPC

Hand/finger symptom/complaint

1.6

6.4

151

966

C03DA01

ATC

spironolactone; oral

1.9

6.4

536

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

14.4

6.4

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

6.4

154

J01MA01

ATC

ofloxacin; systemic

1.9

6.4

478

D07XC01

ATC

betamethasone, combinations; topical

1.8

6.3

106

611

N05BB01

ATC

hydroxyzine; systemic

2.0

6.3

392

S01

ICPC

Pain/tenderness of skin

2.6

6.3

170

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

6.3

111

651

H26.02

ICD-10 Finland

Presenil cataract

3.0

6.3

111

G03.9

ICD-10 Finland

Meningitis, unspecified

11.1

6.3

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.9

6.3

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

9.3

6.3

B01AB10

ATC

tinzaparin; parenteral

2.0

6.3

370

H57.1

ICD-10 Finland

Ocular pain

2.8

6.3

140

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

6.3

470

G44.2

ICD-10 Finland

Tension-type headache

1.6

6.3

153

990

A03FA02

ATC

cisapride; oral, rectal

1.9

6.3

441

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

6.3

100

568

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

18.1

6.3

M07.3

ICD-10 Finland

Other psoriatic arthropathies

18.1

6.3

A06AD11

ATC

lactulose; oral

1.7

6.3

124

754

I20.00

ICD-10 Finland

Unstable angina

3.4

6.3

RJ126

NOMESCO Finland

+∞

6.3

NDF10

NOMESCO Finland

Synovectomy of wrist

+∞

6.3

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

+∞

6.3

N085, M318

ICD-10 Finland

+∞

6.3

M31.2

ICD-10 Finland

Lethal midline granuloma

+∞

6.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

+∞

6.3

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

6.3

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

+∞

6.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

6.3

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

6.3

K74.3

ICD-10 Finland

Primary biliary cirrhosis

+∞

6.3

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

6.3

78890

ICD-8 Finland

Other general symptoms, Hypersedimentatio

+∞

6.3

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

+∞

6.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

6.2

172

1148

QDA50

NOMESCO Finland

Cryotherapy of skin of lower limb

26.8

6.2

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

26.8

6.2

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

26.8

6.2

RJ425

NOMESCO Finland

26.8

6.2

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.5

6.2

-1

NOMESCO Finland

1.4

6.2

364

2840

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

7.1

6.2

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.6

6.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

6.2

135

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

6.2

365

Angiography of the heart and coronary arteries

2.5

6.2

185

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

6.2

481

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.0

6.2

113

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.4

6.2

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.8

6.1

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.8

6.1

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

7.7

6.1

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

6.1

354

A02BX02

ATC

sucralfate; oral

2.5

6.1

186

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

6.1

179

J94.8

ICD-10 Finland

Other specified pleural conditions

4.7

6.1

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.6

6.1

H25.8

ICD-10 Finland

Other senile cataract

1.9

6.1

501

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

6.1

271

S01BC03

ATC

diclofenac; ophthalmic

3.1

6.1

H05BX01

ATC

cinacalcet; oral

12.6

6.1

TK820

NOMESCO Finland

Peritoneal dialysis

10.1

6.0

B02.8

ICD-10 Finland

Zoster with other complications

10.1

6.0

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.2

6.0

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.8

6.0

132

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

6.0

195

1352

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

6.0

232

WZC30

NOMESCO Finland

Teaching

1.7

6.0

127

791

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

799

210

91.29

307.65

6.8

1.1

0.2

0.3

g/l

24.43

769

200

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

437

215

29.53

307.65

2.0

1.1

20.4

2.5

u/ml

3.27

149

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

371

165

30.59

307.65

1.9

1.1

2.2

1.5

u/ml

0.52

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

598

241

43.62

307.65

7.9

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

426

313

19.39

307.65

2.0

1.1

3.2

1.2

u/ml

0.96

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

335

193

22.73

307.65

1.9

1.1

57.8

16.0

u/ml

4.24

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

440

247

25.90

307.65

2.0

1.1

31.5

16.2

u/ml

0.53

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

435

220

28.65

307.65

2.0

1.1

14.5

3.0

u/ml

4.65

174

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

799

221

86.67

307.65

6.7

1.1

1.0

1.3

g/l

17.63

775

209

(3037522) Nuclear Ab [Titer] in Serum

761

1214

13.02

307.65

2.6

1.2

1022.6

337.8

titre

22.26

469

187

(3005719) IgG [Mass/volume] in Serum or Plasma

412

560

10.13

303.62

4.0

2.4

11.3

10.3

g/l

2.64

395

498

(42870588) Differential panel, method unspecified - Blood

920

3076

7.20

279.60

14.1

4.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

171

34.19

264.16

1.7

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

171

34.19

264.16

1.7

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

171

34.19

264.16

1.7

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

171

33.60

262.71

1.7

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

171

33.60

262.71

1.7

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

171

33.60

262.71

1.7

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

151

17.48

257.69

1.6

1.2

5.4

5.0

u/ml

0.07

138

(3001604) Monocytes [#/volume] in Blood

1132

4875

9.03

252.73

15.8

4.0

0.6

e9/l

0.02

1079

4133

(3006315) Basophils [#/volume] in Blood

1134

4898

9.06

252.16

15.8

4.0

0.0

e9/l

3.36

1080

4146

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

219

154

16.77

247.81

1.6

1.2

7.9

3.3

u/ml

1.13

129

(3022096) Basophils/100 leukocytes in Blood

1067

4443

7.59

243.63

16.2

4.1

0.7

0.19

1042

4091

(3013115) Eosinophils [#/volume] in Blood

1144

5103

8.97

241.51

16.3

4.2

0.1

0.2

e9/l

13.50

1093

4410

(3019198) Lymphocytes [#/volume] in Blood

1132

5063

8.51

236.04

15.9

4.0

1.7

2.0

e9/l

11.89

1088

4401

(3006504) Eosinophils/100 leukocytes in Blood

1074

4596

7.45

234.53

16.3

4.0

2.5

2.8

3.08

1046

4231

(3019069) Monocytes/100 leukocytes in Blood

1076

4623

7.45

233.54

16.9

4.2

9.3

8.2

20.08

1046

4288

(3018010) Neutrophils/100 leukocytes in Blood

1082

4726

7.40

228.69

15.7

4.0

58.4

56.6

5.24

1051

4376

(3002030) Lymphocytes/100 leukocytes in Blood

1084

4799

7.29

223.74

16.5

4.1

26.9

28.9

7.48

1049

4427

(3009445) Proteinase 3 Ab [Units/volume] in Serum

260

313

10.04

206.73

2.2

1.1

17.5

—

u/ml

—

(4268621)

172

107

18.27

206.54

2.8

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

304

446

8.50

205.86

1.9

1.7

1.3

1.5

g/l

0.59

279

399

(3013650) Neutrophils [#/volume] in Blood by Automated count

1177

5907

8.56

202.01

18.9

7.4

3.8

4.0

e9/l

3.38

1119

5068

(3004616) Nuclear Ab [Presence] in Serum

159

100

17.88

189.60

1.9

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

172

129

15.13

186.65

1.6

1.4

0.1

iu/ml

0.09

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

121

22.81

162.93

1.7

1.1

59.5

—

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

121

22.42

161.76

1.7

1.1

46.3

—

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

198

236

9.65

157.28

1.6

1.4

603.3

105.0

titre

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

910

4247

4.48

152.81

3.4

2.1

81.5

77.0

nmol/l

5.07

871

3819

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

358

910

4.99

134.38

3.7

4.5

245.1

258.5

u/l

0.51

345

861

(3002179) Metamyelocytes/100 leukocytes in Blood

292

648

5.47

128.14

5.9

3.2

0.3

0.7

1.85

131

(3017181) Myelocytes/100 leukocytes in Blood

307

718

5.24

126.74

6.6

3.3

0.6

0.9

1.47

109

186

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

198

308

7.36

124.85

2.4

1.5

g/l

0.08

180

267

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

678

2880

3.71

123.06

3.0

1.9

180.9

200.4

u/l

0.17

653

2709

(3025159) Blasts/100 leukocytes in Blood

279

644

5.20

116.37

6.7

3.4

0.4

0.6

0.09

144

(3021440) Promyelocytes/100 leukocytes in Blood

290

693

5.05

116.08

6.7

3.3

0.0

0.2

4.09

108

172

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

923

4898

3.77

116.03

10.6

5.6

1.2

mmol/l

1.08

806

4165

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

19.14

110.46

1.3

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

516

1952

3.65

109.59

4.7

2.2

4.3

7.7

e6/l

6.14

463

1676

(3020630) Protein [Mass/volume] in Serum or Plasma

273

649

5.02

109.59

2.0

3.1

66.1

67.3

g/l

1.58

254

590

(3004588) Protein electrophoresis panel - Serum or Plasma

246

535

5.40

109.55

1.9

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1209

7900

5.92

108.79

13.1

3.1

15.6

11.3

mm/h

20.83

1176

7296

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

370

1131

4.12

107.16

3.6

2.1

21.3

23.1

1.65

332

992

(3037467) Urinalysis macro (dipstick) panel - Urine

1157

7380

4.89

105.69

11.3

3.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

388

1243

3.97

104.96

3.5

2.0

2.2

2.4

g/l

9.54

374

1156

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

122

130

10.21

104.53

5.7

5.3

302.1

373.3

iu/ml

0.12

(3022948) Iron [Moles/volume] in Serum or Plasma

408

1366

3.84

103.36

3.4

2.0

11.7

13.7

umol/l

6.74

395

1262

(3018095) Leukocytes [#/volume] in Urine

733

3546

3.32

103.06

8.0

3.1

80.2

74.7

e6/l

0.10

570

2375

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1207

8049

5.57

101.24

16.2

6.1

74.1

76.9

u/l

1.06

1189

7510

(3002582) Erythrocytes [#/volume] in Urine

647

2934

3.31

100.91

6.4

2.6

106.7

73.2

e6/l

0.16

552

2151

(3024561) Albumin [Mass/volume] in Serum or Plasma

807

4172

3.31

100.66

7.5

4.0

34.5

36.1

g/l

11.76

759

3876

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

15.55

100.60

1.4

1.1

ratio

0.99

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

833

4410

3.31

99.33

8.6

5.0

1.2

mmol/l

0.94

784

3985

(3035350) Ketones [Presence] in Urine by Test strip

921

5217

3.39

97.05

6.9

3.2

0.0

estimate

0.50

201

860

(3007164) IgA [Mass/volume] in Serum or Plasma

504

2009

3.40

96.56

1.9

1.4

2.4

2.2

g/l

2.00

349

1183

(3009261) Glucose [Presence] in Urine by Test strip

930

5315

3.39

96.19

6.9

3.2

0.0

estimate

1.32

205

863

(3021601) Nitrite [Presence] in Urine by Test strip

922

5263

3.35

95.12

9.4

4.4

0.0

estimate

0.50

207

875

(3027945) Reticulocytes/100 erythrocytes in Blood

308

893

4.17

95.00

3.8

2.2

1.8

1.7

0.18

285

799

(3030467) Casts [#/volume] in Urine by Automated count

597

2656

3.23

94.88

6.4

2.6

0.2

0.5

e6/l

5.30

497

1911

(3023368) Bacteria identified in Blood by Culture

548

2334

3.26

93.54

6.2

3.8

—

(3011412) CD3 cells [#/volume] in Blood

14.98

91.01

2.5

3.3

0.9

1.1

e9/l

0.81

(3023520) Reticulocytes [#/volume] in Blood

247

635

4.53

88.99

3.2

2.2

70.2

71.6

e9/l

0.18

166

479

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

170

7.86

85.46

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

336

1115

3.68

84.54

9.4

4.6

1.1

1.0

mmol/l

2.63

318

1040

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

23.61

84.17

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

574

2639

3.04

83.95

6.2

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

253

701

4.21

82.25

10.6

6.5

9.7

8.5

mmol/l

1.79

245

666

(3026782) Osmolality of Urine

449

1834

3.17

80.29

5.6

2.4

506.6

542.5

mosm/kgh2o

3.36

407

1541

(40760892) CBC W Ordered Manual Differential panel - Blood

501

2186

3.05

79.69

9.9

3.0

—

(3018418) pH of Serum or Plasma

592

2840

2.93

79.07

6.4

3.4

7.4

0.72

110

500

(40768446) Kidney Pathology biopsy report

26.74

78.10

1.2

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

537

2458

2.96

78.02

3.5

2.8

1332.1

1085.9

ng/l

0.63

479

2051

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

516

2312

2.99

77.94

2.9

2.0

3.0

2.9

mg/l

0.45

468

1949

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

299

5.68

76.83

1.8

2.3

3.3

3.1

g/l

0.82

128

239

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

319

5.51

76.53

1.8

2.3

7.3

7.4

g/l

0.42

130

246

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

319

5.51

76.53

1.8

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

319

5.51

76.53

1.8

2.2

3.6

3.7

g/l

0.61

127

233

(3021589) Normoblasts [#/volume] in Blood

798

4532

2.85

76.53

18.8

7.3

0.0

e9/l

1.05

720

3604

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

293

5.59

73.24

1.8

2.3

11.6

9.9

g/l

3.45

133

257

(3034426) Prothrombin time (PT)

20.10

72.31

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

522

2440

2.85

71.78

5.7

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

305

1051

3.45

71.36

1.6

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

141

275

5.61

69.85

1.9

2.4

0.4

1.0

g/l

1.43

130

250

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

133

246

5.89

69.73

1.8

2.2

0.0

g/l

0.50

125

233

(40768443) Skin Pathology biopsy report

171

398

4.77

69.07

1.3

1.2

—

(40758558) Short blood count panel - Blood

540

2635

2.74

67.52

12.1

5.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

15.38

66.80

2.7

3.3

395.7

748.3

e6/l

0.84

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

428

1880

2.87

65.16

1.4

1.2

44.9

23.2

iu/ml

2.31

148

532

(3036481) Cortisol [Moles/volume] in Serum or Plasma

261

871

3.47

63.71

2.1

2.0

346.3

381.7

nmol/l

1.94

237

797

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

123

230

5.78

63.64

1.9

2.2

0.0

g/l

0.00

116

220

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

408

1770

2.87

63.34

1.3

1.2

15.5

2.5

u/ml

2.97

172

678

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

129

254

5.51

63.12

1.8

2.1

35.7

38.5

g/l

4.06

118

225

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

232

5.73

63.05

1.9

2.2

0.0

g/l

0.00

116

221

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

13.66

62.52

1.9

1.1

5.9

6.1

u/l

0.05

(3013293) Extractable nuclear Ab [Presence] in Serum

117.39

62.43

2.1

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

386

1640

2.89

62.15

5.0

2.3

1.0

1.2

e6/l

0.42

265

866

(3007566) Smooth muscle Ab [Titer] in Serum

116

210

5.95

62.07

1.3

1.2

233.3

74.0

titre

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

7.52

59.84

1.7

1.8

0.5

0.9

g/l

1.35

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

229

735

3.55

59.14

5.6

3.3

90.6

76.1

ng/l

1.91

211

647

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

12.32

57.75

2.2

2.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

158

6.54

57.66

1.3

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

13.35

56.52

2.5

2.9

537.2

554.6

e6/l

0.05

(3004809) Band form neutrophils/100 leukocytes in Blood

114

7.59

56.39

2.7

2.9

0.9

1.8

1.07

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

12.10

56.13

2.1

2.8

11.7

11.9

0.03

(3042936) Bacteria identified in Isolate by Culture

325

1322

2.92

56.08

2.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

118

7.43

55.96

1.6

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

131

7.03

55.69

5.4

2.6

59.2

58.9

0.06

131

(3030905) Polymorphonuclear cells [#/volume] in Blood

122

7.27

55.56

5.2

2.4

3.6

4.5

e9/l

3.02

122

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

833

5322

2.47

55.48

7.2

5.9

10.1

10.8

umol/l

0.88

797

5032

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

149

373

4.36

54.55

1.7

2.1

39.8

40.2

u/l

0.09

132

334

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

343

1463

2.80

53.93

2.4

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

143

6.59

53.57

1.3

1.4

139.5

109.8

u/ml

0.45

(3009508) Creatinine [Moles/volume] in Urine

531

2811

2.46

53.36

6.1

2.8

6.9

7.2

mmol/l

1.10

470

2380

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

15.48

51.28

1.3

1.1

—

(3012516) Albumin [Mass/volume] in Urine

492

2559

2.45

50.93

6.2

2.9

716.4

289.9

mg/l

0.88

344

1516

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

141

6.44

50.73

1.2

1.3

361.8

246.8

u/ml

1.07

(3000475) Leukocytes [#/volume] in Synovial fluid

170

5.87

50.22

1.8

1.6

18192.8

13003.0

e6/l

0.25

126

(3020682) Albumin/Creatinine [Ratio] in Urine

508

2696

2.41

50.12

7.6

3.5

22.3

8.1

mg/mmol

3.20

369

1616

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

30.72

49.92

3.0

4.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

118

265

4.78

49.41

2.2

2.0

108.1

322.8

ug/l

3.47

107

248

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

152

6.12

49.28

1.2

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

199

661

3.36

48.20

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

754

4802

2.29

47.79

4.0

2.6

153.7

93.0

ug/l

7.34

721

4478

(3032080) INR in Blood by Coagulation assay

630

3727

2.29

47.69

12.2

7.8

1.3

1.2

inr

1.24

180

1057

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

344

1555

2.62

47.56

5.6

2.4

3.5

e6/l

1.48

224

789

(3037756) Immunofixation for Serum or Plasma

161

5.85

47.51

1.2

1.7

—

(3037121) Protein [Mass/volume] in Urine

124

299

4.46

47.50

4.8

3.4

0.4

0.2

g/l

1.05

113

(3031040) Bacteria [#/volume] in Urine by Automated count

1001

7222

2.48

46.87

6.8

4.1

1229.8

2488.4

e6/l

0.44

(3018677) aPTT in Platelet poor plasma by Coagulation assay

316

1385

2.67

46.38

2.9

2.1

30.3

29.3

1.47

308

1342

(3034860) Kappa light chains.free [Mass/volume] in Serum

107

235

4.86

45.97

1.9

3.7

49.3

85.7

mg/l

0.60

198

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

107

236

4.84

45.73

1.9

3.7

38.6

66.1

mg/l

0.54

198

(3021447) Carbon dioxide [Partial pressure] in Venous blood

217

784

3.10

45.57

5.0

3.4

5.8

kpa

0.19

207

766

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

13.42

45.27

1.4

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

8.71

44.44

2.8

2.4

60.7

61.2

0.04

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

176

571

3.39

44.11

2.1

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

275

1155

2.73

43.68

2.6

1.3

102.0

80.8

ug/g

0.87

231

865

(3012095) Magnesium [Moles/volume] in Serum or Plasma

327

1499

2.56

43.49

4.0

3.2

0.8

mmol/l

0.00

308

1403

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

344

1620

2.51

43.17

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

102

227

4.78

43.10

1.8

3.6

1.3

1.9

ratio

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

200

5.03

42.87

1.6

1.3

—

(3002032) Base excess in Venous blood by calculation

212

782

3.03

42.80

5.0

3.4

1.8

2.0

mmol/l

0.28

173

641

(3012544) pH of Venous blood

217

814

2.98

42.51

5.0

3.4

—

(3026008) Bacteria identified in Urine by Culture

560

3288

2.20

41.70

3.6

2.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

264

1115

2.70

41.30

2.1

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

332

1574

2.47

40.80

1.9

1.6

1123.6

1156.9

nmol/l

0.29

270

1174

(3026493) Urate [Moles/volume] in Serum or Plasma

450

2440

2.26

40.57

3.8

2.3

4559.3

6041.0

umol/l

0.26

402

2123

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

231

4.54

39.43

1.7

2.2

11.5

11.6

mg/l

0.04

215

(3019174) dRVVT (LA screen)

23.80

38.73

1.5

1.2

—

(3000494) Fungus identified in Specimen by Culture

267

1169

2.60

38.64

1.7

1.4

—

(3017732) Neutrophils [#/volume] in Blood

184

663

3.05

38.52

3.0

2.4

3.8

4.0

e9/l

0.47

127

533

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

113

297

4.06

38.51

2.1

1.8

1.5

1.3

ug/l

0.13

106

262

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

102

249

4.35

38.34

2.7

2.6

—

(3044009) aPTT.lupus sensitive (LA screen)

25.02

38.03

1.6

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

10.54

37.92

2.4

40.4

40.2

0.01

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

226

4.50

37.79

4.5

4.9

1.7

1.4

mg/l

2.24

212

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

438

2419

2.20

37.17

1.4

1.2

1.3

1.4

u/ml

0.04

102

636

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

154

513

3.26

36.77

5.5

3.5

5.1

5.2

kpa

0.20

143

482

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

14.68

36.59

1.6

1.2

—

(44806071)

20.40

36.39

1.1

—

(3019225) pH of Specimen

230

962

2.68

36.36

7.1

3.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

6.91

35.86

3.5

3.8

—

(4062490)

6.91

35.86

1.6

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

14.07

35.73

29.6

101.7

132.9

ug/l

1.07

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

287

3.96

35.42

1.2

1.3

—

(3009343) pH of Capillary blood

151

509

3.21

35.32

5.4

3.5

7.4

0.61

(21494814) CD8 cells/100 lymphocytes in Specimen

14.23

34.87

2.0

2.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

11.16

34.76

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

11.16

34.76

1.4

1.3

—

(3022313) Gas panel - Capillary blood

125

382

3.50

34.17

5.8

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

623

4022

2.02

34.14

2.2

1.8

99.0

96.2

pmol/l

0.76

343

1986

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

230

994

2.58

33.88

2.2

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

6.85

33.74

1.6

1.5

2.7

2.8

g/l

0.14

(3027135) IgG subclass 1 [Mass/volume] in Serum

6.85

33.74

1.6

1.5

7.0

6.6

g/l

0.36

(3024139) IgG subclass 3 [Mass/volume] in Serum

6.85

33.74

1.6

1.5

0.5

0.3

g/l

1.34

(3029075) Extractable nuclear Ab panel - Serum

12.00

33.49

1.6

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

372

2000

2.19

33.19

1.8

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

130

417

3.34

32.92

5.9

3.9

24.1

24.3

mmol/l

0.23

119

380

(3000093) Morphology [Interpretation] in Blood Narrative

7.99

32.90

1.1

—

(3021788) Differential panel - Synovial fluid

131

5.33

32.82

1.7

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

228

1001

2.54

32.41

2.3

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

567

3596

1.99

32.15

3.8

3.3

2.3

2.4

mmol/l

7.26

503

3176

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

143

495

3.11

31.90

5.4

3.4

1.4

1.8

mmol/l

0.57

115

371

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

8.60

31.85

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

226

4.14

31.71

4.2

4.1

0.3

0.4

u/ml

1.98

126

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

23.38

31.52

1.2

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

7.67

31.10

1.4

1.2

—

titre

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

424

2461

2.05

30.52

2.4

1.8

1.6

1.0

mg/l

3.07

342

1861

(40760888) Immunoglobulin light chains.free panel - Serum

172

4.56

30.47

1.8

4.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

7.24

30.22

2.7

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

174

694

2.73

29.92

4.0

2.8

203.0

174.1

ng/l

0.34

161

629

(3029937) Albumin [Presence] in Urine by Test strip

455

2730

2.00

29.71

8.1

3.4

0.0

estimate

1.28

203

861

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

14.48

29.70

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

14.48

29.70

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

14.48

29.70

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

14.48

29.70

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

252

3.84

29.52

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

216

4.08

29.42

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

175

710

2.68

29.07

2.6

2.3

55.2

21.5

au/ml

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

805

5873

1.91

28.93

5.8

3.9

6.2

6.5

mmol/l

2.69

768

5423

(3021960) Folate [Moles/volume] in Serum or Plasma

386

2202

2.05

28.88

1.7

1.5

20.1

20.7

nmol/l

0.36

345

1869

(3000991) Gas panel - Venous blood

179

737

2.65

28.87

8.5

7.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

560

3645

1.91

28.49

4.2

3.1

260.6

40.3

ng/l

0.76

393

2221

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

538

3462

1.92

28.29

4.2

3.0

32.2

32.9

u/l

0.10

516

3307

(3033658) Prothrombin time (PT) actual/Normal

433

2590

1.99

28.26

5.8

3.5

93.2

94.0

0.25

421

2530

(3045424) Erythrocytes [Presence] in Urine

158

4.55

28.08

2.1

1.5

—

(40768797) Stomach Pathology biopsy report

278

1429

2.19

27.15

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

7.08

26.39

1.3

1.1

50.1

41.0

mg/l

0.42

(3024354) Oxygen [Partial pressure] in Venous blood

162

663

2.64

26.36

4.0

3.0

4.6

4.4

kpa

0.71

151

646

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

15.58

26.28

1.4

1.3

8.4

9.0

ug/l

0.18

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

493

3141

1.90

26.27

2.9

2.2

57.5

u/l

0.00

466

2901

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

304

3.40

26.09

4.2

2.9

195.6

174.3

1.48

287

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

102

326

3.30

25.89

3.7

2.5

97.9

92.3

1.71

298

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1271

11184

3.20

25.65

32.5

10.8

18.7

22.8

mg/l

6.06

1158

8500

(3041096) Erythrocytes [Presence] in Urine by Automated

458

2869

1.90

25.57

6.8

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

595

4066

1.83

25.04

7.5

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

354

3.16

25.02

2.5

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

160

4.29

24.98

1.5

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

326

1834

2.02

24.84

5.0

3.2

451.3

258.0

ng/l

0.47

258

1282

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

12.11

24.77

1.9

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

111

387

3.03

24.34

2.6

1.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

229

1135

2.22

24.27

31.5

22.1

1.3

inr

0.20

160

(36660697) Celiac disease serology panel - Serum

191

880

2.36

24.04

1.3

1.1

—

(3036489) Thrombin time

110

390

2.98

23.41

3.6

2.3

22.0

21.1

0.53

339

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

7.16

23.39

1.1

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

263

3.38

22.71

3.9

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

4.08

22.43

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

5.38

22.12

1.8

1.3

56.7

66.1

0.75

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

149

4.17

22.01

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

219

3.57

21.90

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

100

4.94

21.88

1.5

—

(3028433) Virus identified in Specimen by Culture

9.45

21.80

1.3

—

(3045414) Leukocytes [Presence] in Urine

124

488

2.70

21.71

2.3

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

10.16

21.20

2.2

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

126

507

2.64

21.10

2.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

185

887

2.26

21.10

2.4

2.0

0.2

g/l

3.59

170

844

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

221

3.48

20.88

1.6

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

5.19

20.80

1.1

—

(40761535) Cells panel - Urine sediment

164

764

2.30

19.98

7.4

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

504

3453

1.73

19.76

2.9

2.1

—

(3044941) Cell count panel - Synovial fluid

126

4.25

19.70

1.6

1.5

—

(4027681)

6.73

19.63

1.3

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

402

2594

1.78

19.37

2.7

2.1

—

(4306422)

166

3.74

18.97

1.4

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

213

1124

2.06

18.92

2.7

2.9

6.8

7.4

umol/l

0.19

189

966

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

184

3.54

18.40

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

184

3.54

18.40

1.5

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

184

3.54

18.40

1.3

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.64

18.30

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

3.72

17.98

1.4

1.2

—

(3042733) HLA Ab [Presence] in Serum

13.23

17.69

5.7

4.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

5.73

17.32

1.9

1.4

—

(3013512) EKG study

426

2875

1.70

17.12

4.4

3.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1026

8672

1.75

17.09

4.7

3.0

14.7

14.4

pmol/l

4.52

956

7910

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

4.51

16.90

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.15

16.89

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

4.11

16.75

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.55

16.66

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

4.55

16.66

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

154

756

2.17

16.43

5.0

3.2

1.2

mmol/l

1.07

144

649

(3044927) Protein electrophoresis panel - Urine

4.96

16.20

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

4.63

16.17

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

9.62

16.13

1.7

3.1

161.4

211.8

e6/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

137

3.75

16.05

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

238

3.05

16.03

1.6

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

4.78

15.93

1.2

1.0

40.3

52.1

u/l

0.94

(3019150) Specific gravity of Urine by Refractometry

350

2280

1.72

15.81

6.9

3.5

1.0

kg/l

0.87

340

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.94

15.75

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.94

15.75

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.94

15.75

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.94

15.75

1.6

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

4.24

15.63

1.1

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

148

732

2.15

15.47

1.2

135.8

160.2

u/ml

0.27

134

668

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.97

15.28

1.2

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

4.22

15.17

1.1

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

14.14

15.06

1.9

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

7.20

14.85

2.4

2.0

75.8

76.8

ug/l

0.01

(3010144) Erythrocytes [#/volume] in Synovial fluid

4.81

14.76

1.6

1.2

209335.4

232974.7

e6/l

0.04

(3022145) Colonoscopy Study observation

185

1011

1.96

14.72

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.20

14.71

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

10.78

14.66

1.1

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

125

593

2.22

14.49

2.7

3.2

4.2

4.5

pmol/l

4.82

111

529

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

333

2.62

14.47

1.4

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

188

3.18

14.41

3.1

2.7

24.2

24.8

mmol/l

0.39

167

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.05

14.35

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

168

3.31

14.34

1.3

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

168

3.31

14.34

1.6

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

106

3.96

14.29

2.1

2.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

283

2.75

14.23

1.4

334.8

314.4

ug/g

0.34

157

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

5.90

14.02

1.6

2.4

50.1

50.7

umol/l

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

7.09

14.00

1.0

1.1

254.3

188.3

iu/ml

0.26

(3028626) Oxygen [Partial pressure] in Capillary blood

183

3.15

13.73

2.7

3.0

8.5

8.3

kpa

0.42

174

(3017704) Immunofixation for Urine

6.56

13.67

1.0

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

158

3.31

13.64

1.3

1.1

114.0

118.1

0.30

143

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

110

3.81

13.59

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

4.18

13.53

1.2

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

190

3.09

13.52

1.6

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

120

3.67

13.47

1.4

1.1

84.2

97.4

1.64

112

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

144

748

2.04

13.18

2.4

2.2

6.5

5.9

ug/l

0.20

121

655

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.92

13.17

1.6

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

314

2.57

13.04

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1169

10499

1.83

13.02

24.7

10.2

82.9

83.3

ml/min/173m2

0.21

1056

8473

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.28

12.99

1.1

1.0

1.1

u/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

148

3.33

12.94

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

5.66

12.91

1.2

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

660

5200

1.52

12.85

5.1

3.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

111

3.68

12.65

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

5.53

12.61

1.2

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

4.20

12.54

1.2

2.2

—

(3012441) Differential panel - Pleural fluid

4.61

12.39

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.98

12.18

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

112

545

2.15

12.18

1.8

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

149

3.23

12.14

1.3

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1238

11380

2.02

12.05

26.9

12.6

139.1

139.8

mmol/l

12.85

1221

11059

(3023199) Leukocytes [#/volume] in Pleural fluid

4.12

11.89

1.6

1.3

4346.5

2268.0

e6/l

0.63

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

3.31

11.84

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1239

11420

1.99

11.54

27.5

12.7

3.9

mmol/l

0.68

1219

11065

(3014111) Lactate [Moles/volume] in Serum or Plasma

143

777

1.94

11.50

7.9

6.2

1.2

1.3

mmol/l

0.63

137

751

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

204

2.82

11.39

1.3

1.7

15.8

20.5

e6/l

0.20

158

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

285

1899

1.63

11.36

2.8

2.5

mmol/l

0.18

254

1681

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

10.09

11.35

1.0

4.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.27

11.30

1.4

1.3

52865.4

106288.9

e6/l

0.28

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

11.00

11.07

2.0

2.7

—

(3021901) Oxygen saturation in Capillary blood

137

3.21

11.03

2.3

2.5

—

(40768806) Pleura Pathology biopsy report

4.07

10.97

1.4

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.62

10.71

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.32

10.60

1.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.32

10.60

1.5

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.32

10.60

1.5

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.85

10.52

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.85

10.52

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.85

10.52

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.68

10.49

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

10.08

10.45

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.59

10.26

1.5

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

3.40

10.17

1.8

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

5.87

10.08

1.1

546.2

800.4

ng/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

178

2.82

10.05

1.3

1.2

—

(44790048)

114

3.31

10.04

1.7

1.2

—

(44790049)

114

3.31

10.04

1.7

1.2

—

(44806118)

114

3.31

10.04

1.7

1.2

—

(44790047)

114

3.31

10.04

1.7

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

6.14

9.94

1.9

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

100

3.46

9.91

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

110

3.33

9.90

1.8

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

3.30

9.76

1.8

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.88

9.74

1.1

—

(40768441) Liver Pathology biopsy report

4.12

9.72

1.2

1.4

—

(4035726)

162

969

1.76

9.57

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

285

2.38

9.56

1.3

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

10.07

9.55

1.0

9.2

6.7

mg/g

0.42

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1143

10413

1.62

9.46

5.8

3.7

1.9

2.1

mu/l

0.55

1083

9559

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.16

9.46

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.94

9.33

2.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.94

9.33

2.0

1.2

—

(3024471) HLA-A [Type]

7.06

9.29

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.06

9.29

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

4.09

9.26

2.0

1.2

24.9

30.6

0.31

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

136

780

1.83

9.24

3.6

2.2

60.9

71.2

ml/min/173m2

2.36

308

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.62

9.08

1.1

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1271

11960

2.01

8.99

24.6

8.2

25.1

24.6

u/l

0.65

1258

11528

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

184

2.67

8.92

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

159

965

1.73

8.91

2.8

2.2

39.8

40.6

u/l

0.05

137

813

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.73

8.90

1.0

1.1

—

(3024932) HLA-DR beta [Type]

6.73

8.90

1.0

1.2

—

(40768804) Tissue Pathology biopsy report

585

4730

1.42

8.78

2.3

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

181

2.65

8.66

5.7

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

289

2046

1.52

8.64

1.6

77108874.1

47719728.3

pmol/l

0.21

249

1710

(3023419) Bacteria identified in Sputum by Culture

115

3.10

8.59

2.4

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

107

3.14

8.28

1.9

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.14

8.19

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.40

8.16

1.6

1.5

17.4

3.1

u/l

0.59

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

108

3.11

8.16

1.9

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

135

2.87

8.16

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

103

3.16

8.13

2.5

4.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

109

3.08

8.04

1.9

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

7.11

8.00

1.2

1.1

1.3

64.2

ug/l

—

(3016502) Oxygen saturation in Arterial blood

142

864

1.72

7.88

7.2

6.9

94.7

96.0

0.86

137

833

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.88

7.86

1.1

—

(3042631) Mycobacterium sp identified in Specimen

111

3.02

7.80

2.7

2.4

—

(3045788) Cell count panel - Pleural fluid

3.68

7.75

1.5

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

159

1004

1.66

7.68

7.4

6.4

4.8

5.1

kpa

2.74

150

964

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

18.47

7.60

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

3.20

7.56

1.4

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

3.42

7.54

4.5

2.5

89.4

14.1

mg/l

0.85

(3044889) 12 lead EKG panel

860

7532

1.39

7.54

4.2

3.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

183

2.51

7.47

1.6

2.3

134.2

129.4

g/l

0.72

128

(3027801) Oxygen [Partial pressure] in Arterial blood

158

1004

1.65

7.45

7.5

6.4

11.3

13.1

kpa

5.60

150

965

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

+∞

7.30

1.3

0.0

5.7

—

mg/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

144

2.69

7.26

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

15.84

7.23

2.5

3.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.04

7.19

1.1

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

839

7347

1.37

7.18

4.0

2.8

59.2

40.9

u/l

2.96

798

6878

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.75

7.17

2.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.75

7.17

2.0

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

195

1317

1.56

7.14

4.6

4.2

34.4

32.5

1.44

147

868

(3025941) Bacteria identified in Stool by Culture

106

612

1.79

7.06

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.23

6.98

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.40

6.97

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

143

2.63

6.82

1.4

1.3

49.6

60.2

mmol/l

0.81

111

(4015189)

6.52

6.78

2.6

4.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.29

6.76

1.2

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.19

6.70

1.1

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.60

6.60

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

154

1002

1.61

6.60

7.4

6.5

0.7

1.0

mmol/l

0.29

124

799

(3003327) Ova and parasites identified in Stool by Light microscopy

354

2.00

6.60

2.3

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

12.31

6.58

1.8

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.84

6.54

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.36

6.50

1.8

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

6.15

6.43

1.1

1.2

—

(40761536) Microorganisms panel - Urine sediment

131

828

1.64

6.31

9.7

3.4

—

(3024263) Appearance of Synovial fluid

4.25

6.29

2.2

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

3.03

6.25

1.4

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.45

6.24

1.1

1.0

92.2

94.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

299

2.05

6.22

1.3

1.2

—

(1616796) Gas panel - Central venous blood

151

2.49

6.14

4.3

3.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.48

6.02

1.2

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.26

6.01

1.1

1.6

—

(3017569) Oxygen content in Arterial blood

4.55

5.99

3.8

3.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

463

1.82

5.91

9.5

8.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

15.08

5.90

1.2

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

119

2.64

5.83

3.0

2.1

34.2

24.7

mg/l

0.32

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.20

5.83

1.1

1.0

90.7

90.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

115

718

1.66

5.82

1.3

1.2

94.4

92.6

iu/ml

0.02

238

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

11.18

5.80

1.2

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.04

5.75

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

316

1.97

5.71

1.3

1.1

—

(3008898) HLA-B27 [Presence]

360

1.91

5.64

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.27

5.53

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.52

5.51

1.1

1.0

1446.0

1401.1

miu/ml

0.05

(3002173) Hemoglobin [Mass/volume] in Arterial blood

127

827

1.59

5.44

7.9

7.2

115.2

120.4

g/l

2.12

122

793

(1761868) Lipid panel - Serum or Plasma

329

4109

0.74

5.39

2.6

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

161

2.33

5.38

2.6

2.2

87.0

98.7

ug/min

0.08

(3024928) Oxygen saturation in Venous blood

187

2.23

5.35

5.3

3.0

—

(3002385) Erythrocyte distribution width [Ratio]

1023

9415

1.35

5.33

35.3

13.5

13.9

13.6

7.71

1018

9193

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.03

5.26

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.21

8.0

0.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

5.21

8.0

0.0

25.9

—

mg/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.91

5.20

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

320

1.92

5.19

1.3

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

197

2.17

5.14

2.8

2.5

1.1

1.5

mmol/l

5.55

191

(3027456) Digoxin [Moles/volume] in Serum or Plasma

159

2.30

5.08

3.4

3.0

0.8

nmol/l

0.11

129

(4010399)

116

753

1.59

5.04

1.6

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.81

5.02

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.81

5.02

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

124

2.45

4.90

1.1

1.3

293.5

304.6

pmol/l

0.09

(3044242) Glucose [Moles/volume] in Arterial blood

4.09

4.90

4.0

3.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.95

4.88

1.0

—

(21494434) Karyotype in Bone marrow

2.85

4.83

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.32

4.83

1.1

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

119

2.47

4.81

2.6

1.8

230.7

5.6

u/ml

0.81

111

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.77

4.79

4.0

2.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

326

1.85

4.61

1.3

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

14.06

4.58

1.4

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

2.74

4.52

2.7

3.8

6.6

mmol/l

0.00

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.05

4.52

1.1

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

140

975

1.49

4.44

3.9

2.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

544

1.64

4.43

2.4

2.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1077

10092

1.33

4.23

5.9

4.8

38.4

mmol/mol

0.02

1022

9364

(3011648) Oxygen content in Venous blood

2.77

4.19

3.6

3.0

11.2

10.6

0.24

(3008536) Aspergillus sp Ab [Presence] in Serum

6.96

4.16

1.1

2.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.61

4.15

1.2

1.1

—

(3010421) pH of Blood

208

2.00

4.15

4.5

2.8

7.4

0.48

165

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

188

2.05

4.11

1.3

25.0

22.9

u/l

0.12

157

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.10

4.09

1.1

1.3

—

(3000492) Spirometry study

146

1046

1.44

4.02

1.9

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

10.04

4.01

2.1

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

164

2.10

3.94

2.3

17.1

16.1

0.88

(3022621) pH of Urine by Test strip

110

752

1.50

3.84

4.2

2.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

12.04

3.76

1.0

—

(3014271) Vancomycin [Susceptibility]

3.36

3.76

3.8

2.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

2.13

3.76

1.1

1.2

126.0

18.4

u/l

1.11

128

(3026389) Candida sp identified in Specimen by Organism specific culture

154

2.10

3.74

1.6

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1110

0.63

3.64

1.4

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

3.45

3.62

3.6

11.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.45

3.62

1.8

1.2

4.6

0.8

—

(21494755) Public health laboratory ask at order entry panel

1224

0.65

3.58

1.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

843

7728

1.24

3.58

3.7

3.2

—

(3019060) Gas panel - Arterial blood

567

1.55

3.56

3.8

4.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

7.81

3.56

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

149

1098

1.40

3.52

3.1

4.2

9.7

22.7

ug/l

0.99

112

857

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.19

3.50

1.5

2.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.04

3.50

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.49

3.47

1.8

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

159

2.04

3.47

1.2

1.0

4.3

2.3

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

654

1.50

3.43

1.0

—

(40768795) Lymph node Pathology biopsy report

113

2.24

3.42

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

107

2.27

3.39

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

281

2289

1.29

3.39

1.6

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.03

3.36

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.74

3.34

2.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.38

3.32

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.60

3.26

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

347

2921

1.25

3.18

1.7

1.6

1.3

mmol/l

0.14

311

2477

(3025130) Human papilloma virus identified in Specimen

216

1.83

3.12

1.8

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.53

3.05

1.2

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.45

3.05

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

5.02

3.05

1.9

2.1

—

(3012501) Base excess in Blood by calculation

168

1.93

3.01

5.3

3.0

3.1

2.4

mmol/l

0.72

106

(3008152) Bicarbonate [Moles/volume] in Arterial blood

521

1.51

2.88

5.6

6.3

24.5

24.6

mmol/l

0.09

482

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.11

2.88

1.3

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.60

2.88

2.1

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.69

2.87

1.0

4.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.36

2.82

2.7

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

2.24

2.81

5.5

3.5

—

(40757373) Influenza virus identified in Isolate

3.93

2.77

2.0

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.33

2.75

1.5

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.36

2.75

1.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

416

1.54

2.66

1.2

1.3

208.7

227.4

miu/ml

0.16

214

(3035880) pH of Pleural fluid

2.91

2.58

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

660

0.61

2.56

1.4

—

(3026726) Creatinine [Moles/volume] in Specimen

7.17

2.55

2.8

3.0

308.8

484.7

umol/l

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.68

2.45

2.9

2.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.47

2.45

1.6

1.4

1.7

1.8

u/field

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

384

1.53

2.44

3.4

3.2

791.9

745.4

u/ml

0.02

332

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.02

2.40

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.02

2.40

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

779

0.65

2.38

1.3

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.27

2.37

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

6.27

2.37

1.0

1.1

—

(40761511) CBC panel - Blood by Automated count

1218

11818

1.30

2.28

23.7

10.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

178

1.76

2.27

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.63

2.27

2.2

2.5

—

(3049717) Cytology report of Urine Cyto stain

287

1.59

2.24

2.3

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

179

1.75

2.24

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

128

1.89

2.22

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.57

2.21

1.2

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.57

2.21

1.2

—

(3000330) Specific gravity of Urine by Test strip

539

1.41

2.13

6.9

3.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

252

1.61

2.11

5.6

4.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

2.07

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

103

1.96

2.06

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.51

2.05

1.1

1.2

—

(3051651) Icteric interference index of Serum or Plasma

2.33

2.05

7.1

3.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

1.85

2.03

1.4

1.3

—

nmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1107

10656

1.21

2.02

4.2

3.6

1.3

1.2

mmol/l

0.62

1038

9822

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

151

1216

1.27

2.02

1.5

1.8

1.4

0.69

130

1087

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.23

2.01

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.04

1.96

1.6

2.0

2.7

2.2

u/field

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

127

1.83

1.94

1.5

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.97

1.93

3.5

4.2

—

(40765096) Chromosome analysis panel by Banding

2.97

1.93

1.0

—

(3048879) Bone marrow aspiration report

3.76

1.93

1.2

3.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

113

1.87

1.92

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

275

1.54

1.91

1.4

1.3

11.8

u/l

0.01

223

(4211845)

2.25

1.91

5.1

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.13

1.82

2.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.13

1.82

2.1

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

617

1.35

1.81

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

676

0.68

1.81

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.58

1.80

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

367

0.59

1.67

1.5

1.4

—

(3022689) Creatine [Moles/volume] in Urine

3.17

1.66

3.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

366

0.59

1.65

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

365

0.60

1.64

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

365

0.60

1.64

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1165

11324

1.21

1.61

5.0

4.4

2.6

2.9

mmol/l

28.22

1095

10490

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

399

0.62

1.60

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.70

1.58

1.7

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

311

0.57

1.57

1.6

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

2.12

1.55

1.2

1.7

—

7.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1141

11086

1.19

1.50

4.6

4.0

1.5

mmol/l

2.06

1075

10273

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

458

1.35

1.41

1.5

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

301

0.59

1.41

1.6

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

189

1.55

1.41

1.8

1.3

—

(3006462) Nitrate [Presence] in Urine

2.08

1.38

5.8

2.1

—

(3005033) Fetal Nuchal fold Thickness US

299

0.60

1.38

1.6

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

265

1.45

1.35

2.7

2.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

105

1.72

1.33

3.0

2.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1144

11145

1.17

1.31

4.6

4.0

4.5

4.8

mmol/l

23.98

1082

10379

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.36

1.29

3.5

3.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.78

1.28

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

2.05

1.27

1.1

1.5

—

(3008295) Osmolality of Serum or Plasma

1.75

1.25

1.1

1.5

269.4

279.5

mosm/kgh2o

0.93

(3007461) Platelets [#/volume] in Blood

1285

12665

1.28

1.24

43.7

16.1

252.3

258.7

e9/l

2.54

1273

12321

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

148

1263

1.19

1.21

6.9

5.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

238

1.44

1.21

5.7

3.4

31.3

23.3

mg/l

0.83

141

(3050129) First trimester maternal screen panel - Serum or Plasma

430

0.69

1.21

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

133

1.59

1.17

1.3

1.6

—

(3024731) MCV [Entitic volume]

1285

12673

1.27

1.16

43.5

16.1

91.5

90.7

7.60

1279

12494

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.51

1.15

2.4

3.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.51

1.15

2.4

3.5

—

(3026361) Erythrocytes [#/volume] in Blood

1285

12676

1.27

1.14

43.7

16.1

4.3

4.5

e12/l

28.23

1269

12296

(3035941) MCH [Entitic mass]

1285

12676

1.27

1.14

43.4

16.1

30.2

0.95

1279

12496

(4094501)

270

0.62

1.13

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

1285

12679

1.26

1.11

43.8

16.2

6.4

6.6

e9/l

1.98

1271

12293

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.39

1.09

1.6

1.3

38.2

25.5

g/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

1285

12682

1.26

1.08

44.0

16.2

129.4

134.1

g/l

30.85

1278

12500

(3029396) Erythrocyte agglutination [Presence] in Blood

2.19

1.08

1.7

3.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.28

1.03

2.0

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

323

0.68

1.03

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

248

1.38

1.00

2.1

1.6

9.3

3.3

iu/l

0.90

(4024509)

1.62

1.00

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

156

1.48

0.99

2.1

2.7

5.7

5.1

umol/l

0.19

111

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.84

0.98

2.1

2.4

800.5

20.1

ug/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.97

0.0

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1119

10942

1.13

0.96

4.7

4.2

5.6

5.8

mmol/l

5.30

1047

10033

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

499

0.75

0.94

1.5

1.7

7.4

3.9

mg/l

0.50

359

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.75

0.90

1.1

1.7

4.5

8.3

ug/l

1.25

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.70

0.89

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.00

0.87

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.82

0.86

1.1

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

138

1211

1.16

0.85

1.6

—

(4034850)

386

0.75

0.81

27.4

7.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

248

0.68

0.81

1.2

1.1

1.5

1.1

u/ml

—

103

(44806420)

0.00

0.79

0.0

2.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

488

1.22

0.74

1.7

2.0

8844.6

5170.7

u/l

0.25

202

(3036071) Salmonella sp Ab [Titer] in Serum

1.85

0.73

1.4

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.93

0.70

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.85

0.68

1.6

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

797

0.85

0.66

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.59

0.65

3.6

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

120

1343

0.88

0.64

1.8

—

(3000012) Reticulocyte production index

1.64

0.62

2.5

1.5

—

(4281824)

164

0.67

0.61

1.5

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.60

0.0

1.1

—

219.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

309

0.77

0.58

1.3

—

(4146454)

1.49

0.57

4.1

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

153

1395

1.11

0.57

3.9

4.6

1.7

2.4

ug/l

1.56

132

1246

(3023323) Follitropin [Units/volume] in Serum or Plasma

730

1.15

0.55

1.4

35.6

30.6

iu/l

0.57

632

(3035933) Granulocytes/100 leukocytes in Blood

1.58

0.54

1.3

1.5

—

(3004451) EKG impression Narrative

1.58

0.54

1.5

1.3

—

(3020891) Body temperature

349

1.21

0.54

3.6

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

157

1441

1.10

0.52

1.7

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

192

0.73

0.52

1.4

1.8

—

(3005570) Glucose [Moles/volume] in Urine

100

1.40

0.52

2.3

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

203

0.74

0.52

1.1

0.1

1.5

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

281

0.78

0.51

1.8

1.6

—

(3002256) Pathology report gross observation

162

1493

1.10

0.50

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

1069

10529

1.07

0.48

30.2

12.1

37.6

39.5

7.78

774

7963

(3019897) Erythrocyte distribution width [Ratio] by Automated count

166

0.72

0.48

7.4

1.9

14.5

13.2

1.33

166

(3021387) Prolactin [Units/volume] in Serum or Plasma

458

1.16

0.46

1.4

1.6

224.9

316.1

mu/l

3.48

414

(3033799) Differential panel - Peritoneal fluid

1.52

0.41

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.47

0.40

1.0

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.35

0.38

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

274

2612

1.06

0.37

1.7

1.4

—

(44813793)

1.36

0.36

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.36

0.36

1.1

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

212

0.80

0.35

1.2

1.1

7.3

4.9

u/ml

—

105

(4198724)

1.40

0.35

1.0

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

209

1.20

0.34

1.4

1.6

—

(40768800) Prostate Pathology biopsy report

0.67

0.32

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

271

0.85

0.29

2.1

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.25

0.29

1.1

1.4

—

(1002224) Polysomnography panel

462

1.11

0.26

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

136

1287

1.06

0.26

1.7

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.68

0.26

1.0

1.7

0.8

1.3

promille

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.19

0.24

1.1

1.4

—

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

402

0.89

0.24

1.9

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

233

0.86

0.24

1.2

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

180

1.17

0.23

1.7

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

727

1.08

0.23

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.25

0.22

1.2

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

146

0.82

0.22

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

5.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

522

0.92

0.21

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

173

1.16

0.21

1.8

1.6

35.6

42.9

nmol/l

1.09

168

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

49.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.20

0.16

1.3

1.5

17.9

11.6

mmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.15

0.15

1.2

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

198

1.11

0.14

1.9

1.7

0.9

nmol/l

0.08

167

(3027008) Opiates [Presence] in Urine

407

0.93

0.13

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

328

3222

1.02

0.13

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.18

0.12

1.2

1.4

1.0

0.9

g/l

—

(3016879) Cocaine [Presence] in Urine

375

0.93

0.12

1.5

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

281

0.92

0.11

3.3

3.7

28.7

34.8

u/ml

0.22

274

(3027944) Amphetamines [Presence] in Urine

401

0.95

0.09

1.5

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

155

0.90

0.09

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

410

0.95

0.08

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.05

0.08

1.0

1.2

436.0

448.9

u/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

128

1251

1.03

0.08

1.6

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.83

0.07

4.0

6.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.82

0.07

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

215

1.07

0.07

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

0.81

0.07

1.2

—

(3006270) Folate [Moles/volume] in Blood

1.02

0.07

1.4

1.1

322.5

403.0

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

407

0.96

0.06

1.5

1.6

—

(40768793) Breast Pathology biopsy report

376

0.96

0.06

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

101

0.89

0.06

1.6

7.1

7.9

mmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

101

0.89

0.06

1.0

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

562

1.03

0.06

1.7

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

112

1140

0.98

0.05

3.2

4.0

21.8

20.7

0.29

516

(1001926) Buprenorphine [Presence] in Urine by Screen method

313

0.96

0.05

1.6

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.10

0.04

1.3

1.2

0.0

0.2

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

142

1.06

0.02

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

846

0.99

0.00

2.6

2.8

0.8

0.7

ug/l

0.12

535

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

924

1.01

0.00

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

409

1.00

0.00

1.4

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

8.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.96

0.00

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

19.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.93

0.00

1.2

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.96

0.00

1.2

1.4

119.8

139.1

nmol/l

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.02

0.00

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.95

0.00

1.5

1.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

2.0

—

281.4

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

200.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

9.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint SLE_FG and mortality.

Females

Parameter	HR [95% CI]	p-value
SLE_FG	1.847 [1.66, 2.06]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 872 out of 4580 females with SLE_FG died.

Males

Parameter	HR [95% CI]	p-value
SLE_FG	1.968 [1.64, 2.36]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 350 out of 1122 males with SLE_FG died.

Mortality risk

Mortality risk for people of age

years, who have SLE_FG.

N-year risk	Females	Males
1	0.183%	0.363%
5	0.936%	2.409%
10	2.457%	5.824%
15	4.534%	10.77%
20	7.396%	17.715%

Relationships between endpoints

↥

Index endpoint: SLE_FG – SLE (Finngen)

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

SLE (Finngen)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints